![John Lunger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Lunger
Nessuna posizione attualmente
Patrimonio netto: 1 776 $ in data 31/05/2026
Profilo
John Lunger formerly worked at Genocea Biosciences, Inc., as Independent Director, Merrimack Pharmaceuticals, Inc., as Head-Supply Chain & Commercial Product Supply, and Adaptimmune Therapeutics Plc, as Chief Patient Supply Officer from 2019 to 2025.
Mr. Lunger received his undergraduate degree from United States Naval Academy and Masters Business Admin degree from The University of Chicago Booth School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/04/2025 | 1.025.340 ( 0,06% ) | 1 025 $ | 31/05/2026 | |
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes 0,16% | 17/01/2025 | 7.510 ( 0,16% ) | 751 $ | 31/05/2026 |
Precedenti posizioni note di John Lunger
| Società | Posizione | Fine |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 29/08/2025 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
| GENOCEA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | - |
Formazione di John Lunger
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
United States Naval Academy
 United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
